Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 May 5;41(5):1801-1809.
doi: 10.1161/ATVBAHA.121.316083. Epub 2021 Mar 18.

Impaired Peripheral Microvascular Function and Risk of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease

An Young  1   2 , Mariana Garcia  1   2 , Samaah M Sullivan  1 , Chang Liu  1 , Kasra Moazzami  1   2 , Yi-An Ko  3 , Amit J Shah  1   2   4 , Jeong Hwan Kim  2 , Brad Pearce  1 , Irina Uphoff  1 , J Douglas Bremner  5   4 , Paolo Raggi  6 , Arshed Quyyumi  2 , Viola Vaccarino  1   2
Affiliations
Observational Study

Impaired Peripheral Microvascular Function and Risk of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease

An Young et al. Arterioscler Thromb Vasc Biol. .

Abstract

[Figure: see text].

Keywords: coronary artery disease; hyperemia index; interleukin; myocardial infarction; risk factors.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Kaplan Meier Analysis of Major Adverse Cardiovascular Outcomes and Reactive Hyperemia Index by Tertiles (Unadjusted)
Panel A. Cumulative Incidence of Cardiovascular Death and Myocardial Infarction Panel B. Cumulative Incidence of Cardiovascular Death, Myocardial Infarction, and Heart Failure Hospitalization
Figure 1.
Figure 1.. Kaplan Meier Analysis of Major Adverse Cardiovascular Outcomes and Reactive Hyperemia Index by Tertiles (Unadjusted)
Panel A. Cumulative Incidence of Cardiovascular Death and Myocardial Infarction Panel B. Cumulative Incidence of Cardiovascular Death, Myocardial Infarction, and Heart Failure Hospitalization
Figure 2.
Figure 2.. Forest Plot for the Adjusted Association of Reactive Hyperemia Index with Individual Components of the Composite Cardiac Endpoints. Values Shown are Subdistribution Hazard Ratios and 95% Confidence Intervals per Standard Deviation Decrease in Reactive Hyperemia Index.
Estimates are adjusted for age, sex, race, income, hypertension, diabetes, dyslipidemia, smoking status, BMI, history of MI, heart failure, Gensini score, and medication use (beta blockers, angiotensin converting enzyme inhibitors/angiotensin receptor blockers or statins)
See this image and copyright information in PMC

References

    1. Furman MI, Dauerman HL, Goldberg RJ, Yarzebski J, Lessard D and Gore JM. Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective. J Am Coll Cardiol. 2001;37:1571–80. - PubMed
    1. Boden WE, O’Rourke RA, Teo KK, Maron DJ, Hartigan PM, Sedlis SP, Dada M, Labedi M, Spertus JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR, Mancini GB, Weintraub WS and Investigators CT. Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial). Am J Cardiol. 2009;104:1–4. - PubMed
    1. Malenka DJ, Kaplan AV, Lucas FL, Sharp SM and Skinner JS. Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents. JAMA. 2008;299:2868–76. - PMC - PubMed
    1. Kostis JB, Breazna A, Deedwania PC, LaRosa JC, Treating to New Targets Steering C and Investigators. The benefits of intensive lipid lowering in patients with stable coronary heart disease with normal or high systolic blood pressure: an analysis of the Treating to New Targets (TNT) study. J Clin Hypertens (Greenwich). 2008;10:367–76. - PMC - PubMed
    1. Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, Gibbons RJ, Grundy SM, Hiratzka LF and Jones DW. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. Journal of the American college of cardiology. 2011;58:2432–2446. - PubMed

Publication types

MeSH terms